Kristine Peterson's Net Worth

$2.88 Million

Estimate Recalculated Jul 16, 2024 03:25PM EST

Who is Kristine Peterson?

Kristine Peterson has an estimated net worth of $2.88 Million. This is based on reported shares across multiple companies, which include ENANTA PHARMACEUTICALS INC, AMARIN CORP PLC\UK, ImmunoGen, Inc., EyePoint Pharmaceuticals, Inc., and Paratek Pharmaceuticals, Inc..

SEC CIK

Kristine Peterson's CIK is 0001508596

Past Insider Trading and Trends

2019 was Kristine Peterson's most active year for acquiring shares with 12 total transactions. Kristine Peterson's most active month to acquire stocks was the month of May. 2023 was Kristine Peterson's most active year for disposing of shares, totalling 13 transactions. Kristine Peterson's most active month to dispose stocks was the month of August. 2019 saw Kristine Peterson paying a total of $985,530.00 for 266,753 shares, this is the most they've acquired in one year. In 2019 Kristine Peterson cashed out on 333,667 shares for a total of $3,274,038.45, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ENANTA PHARMACEUTICALS INC (ENTA) Snapshot price: $12.54

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 6
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
—
—
0
Mar 3
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
—
—
0
Feb 26
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
—
—
0
Sep 11
Form 3
—
0
—
—
0
No matching records found

AMARIN CORP PLC\UK (AMRN) Snapshot price: $1.195

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 27
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jul 13
Form 4
—
0
—
—
0
May 20
Form 4
—
0
$12.91
-$2,326,308.45
0
Scheduled
Feb 22
Form 4
—
0
—
—
0
May 14
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
Jul 11
Form 4
—
0
—
—
0
Jul 6
Form 4
—
0
—
—
0
Mar 11
Form 4
—
0
—
—
0
Jul 9
Form 4
—
0
—
—
0
Jul 10
Form 3
—
0
—
—
0
No matching records found

ImmunoGen, Inc. (IMGN) Snapshot price: $29.6

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 12
Form 4
—
0
$20.24
-$346,300.00
0
Scheduled
Nov 30
Form 4
—
0
$15.39
-$13,800.00
0
Sep 13
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Dec 9
Form 4
—
0
—
—
0
Nov 10
Form 4
—
0
—
—
0
Nov 11
Form 4
—
0
—
—
0
Nov 12
Form 4
—
0
—
—
0
Jan 30
Form 4
—
0
—
—
0
Nov 13
Form 3
—
0
—
—
0
No matching records found

EyePoint Pharmaceuticals, Inc. (EYPT) Snapshot price: $29.35

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
—
—
0
Jun 25
Form 4
∞
6.67K
—
—
6.67K
Jun 21
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Dec 15
Form 3
—
0
—
—
0
No matching records found

Paratek Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-79.00K
—
—
0
Sep 21
Form 4
+33.90%
20K
—
—
79K
Feb 8
Form 4
+51.28%
20K
—
—
59K
Feb 16
Form 4
+30.00%
9K
—
—
39K
Feb 18
Form 4
+42.86%
9K
—
—
30K
Feb 19
Form 4
+55.56%
7.5K
—
—
21K
Feb 26
Form 4
+125.00%
7.5K
—
—
13.5K
Feb 14
Form 4
∞
6K
—
—
6K
Feb 2
Form 4
—
0
—
—
0
Mar 31
Form 3
—
0
—
—
0
No matching records found